Abstract:Chronic infection with the gastric bacterial pathogen Helicobacter pylori causes gastric adenocarcinoma in a particularly susceptible fraction of the infected population. The intestinal type of gastric cancer is preceded by a series of preneoplastic lesions that are of immunopathological origin, and that can be recapitulated by experimental infection of C57BL/6 mice with Helicobacter species. Several lines of evidence suggest that specific T cell subsets and/or their signature cytokines contribute to the control of Helicobacter infections on the one hand, and to the associated gastric preneoplastic pathology on the other. Here, we have used virulent H. pylori and H. felis isolates to infect mice that lack α/β T cells due to a targeted deletion of the T cell receptor β-chain, or are deficient for the unique p35 and p19 subunits of the Th1- and Th17-polarizing cytokines interleukin (IL)-12 and IL-23, respectively. We found that α/β T cells are absolutely required for Helicobacter control and for the induction of gastric preneoplastic pathology. In contrast, neither IL-12-dependent Th1 nor IL-23-dependent Th17 cells were essential for controlling the infection; IL-12p35(-/-) and IL-23p19(-/-) mice did not differ significantly from wild type animals with respect to Helicobacter colonization densities. Gastritis and gastric preneoplastic pathology developed to a similar extent in all three strains upon H. felis infection; in the H. pylori infection model, IL-23p19(-/-) mice exhibited significantly less gastritis and precancerous pathology. In summary, the results indicate that neither Th1 nor Th17 cells are by themselves essential for Helicobacter control; the associated gastric pathology is reduced only in the absence of Th17-polarizing IL-23, and only in the H. pylori, but not the H. felis infection model. The results thus suggest the involvement of other, as yet unknown T cell subsets in both processes.

An intestinal T H 17 cell-derived subset can initiate cancer

A Paradigm Shift in Tumor Immunology: Th17 Cells and TGF-β in Intestinal Cancer Initiation

T helpers ? More like T troublemakers

Th17 cells and colorectal cancer

Alterations in the Microbiota Drive Interleukin-17C Production from Intestinal Epithelial Cells to Promote Tumorigenesis.

The role of Th cell subsets in the control of Helicobacter infections and in T cell-driven gastric immunopathology

Innate Γδt17 Cells Convert Cancer-Elicited Inflammation into Immunosuppression Through Myeloid-Derived Suppressor Cells

TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis

Γδt17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer.

F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis

IL-33 activates tumor stroma to promote intestinal polyposis

The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer

Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development

Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

Mechanism of IL-17 in Colorectal Inflammation-Cancer Transition

Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis

Tumor-Elicited Inflammation and Colorectal Cancer

An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis

A Protective Role by Interleukin-17F in Colon Tumorigenesis

IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer

Deficiency of the Immunostimulatory Cytokine Il-21 Promotes Intestinal Neoplasia Via Dysregulation of the Th1/Th17 Axis